![CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d372495d-2031-45c2-b366-68ebb0b22ec9/iji12485-fig-0001-m.jpg)
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box - Ellwanger - 2020 - International Journal of Immunogenetics - Wiley Online Library
![TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection](https://www.spandidos-publications.com/article_images/mmr/17/1/MMR-17-01-0243-g01.jpg)
TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection
![According to an analysis by scientists from the University of California, Berkeley, the genetic mutation that a Chinese scientist attempted to create in twin babies born last year is associated with a According to an analysis by scientists from the University of California, Berkeley, the genetic mutation that a Chinese scientist attempted to create in twin babies born last year is associated with a](https://vajiramandravi.s3.us-east-1.amazonaws.com/media/2019/6/10/13/51/6/CC.jpg)
According to an analysis by scientists from the University of California, Berkeley, the genetic mutation that a Chinese scientist attempted to create in twin babies born last year is associated with a
![Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science](https://www.eurekaselect.com/public/images/graphical-abstract/chr/17/5/001.jpg)
Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV | Bentham Science
![Frontiers | CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, and Social Implications Frontiers | CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, and Social Implications](https://www.frontiersin.org/files/Articles/790041/fimmu-12-790041-HTML/image_m/fimmu-12-790041-g001.jpg)
Frontiers | CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, and Social Implications
![Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation](https://vajiramandravi.s3.us-east-1.amazonaws.com/media/2023/2/24/13/8/52/CCR5_Delta_32_mutation.png)
Recently, the man referred to as the "Dusseldorf patient" became at least the third person to have been “cured of HIV” after a bone marrow transplant carrying a specific HIV-resistant mutation
![CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice: Molecular Therapy - Methods & Clinical Development CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/76d5b2ff-a0e6-4a44-93c3-2f1173a22831/fx1_lrg.jpg)
CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice: Molecular Therapy - Methods & Clinical Development
![Receptor editing using crispr-cas9.HIV enters the cell by binding CD4... | Download Scientific Diagram Receptor editing using crispr-cas9.HIV enters the cell by binding CD4... | Download Scientific Diagram](https://www.researchgate.net/publication/362963292/figure/fig2/AS:11431281084118090@1663034194658/Receptor-editing-using-crispr-cas9HIV-enters-the-cell-by-binding-CD4-receptor-and-CXCR4.png)
Receptor editing using crispr-cas9.HIV enters the cell by binding CD4... | Download Scientific Diagram
![Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair](https://www.frontiersin.org/files/Articles/835994/fimmu-13-835994-HTML-r1/image_m/fimmu-13-835994-g001.jpg)
Frontiers | CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair
![BioTech | Free Full-Text | Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV BioTech | Free Full-Text | Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV](https://pub.mdpi-res.com/biotech/biotech-11-00025/article_deploy/html/images/biotech-11-00025-ag.png?1657803144)
BioTech | Free Full-Text | Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV
![CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00410-6/MediaObjects/13578_2020_410_Fig1_HTML.png)